The Leukocyte Integrin Antagonist Del-1 Inhibits IL-17-mediated Inflammatory Bone Loss
Overview
Authors
Affiliations
Aging is linked to greater susceptibility to chronic inflammatory diseases, several of which, including periodontitis, involve neutrophil-mediated tissue injury. Here we found that aging-associated periodontitis was accompanied by lower expression of Del-1, an endogenous inhibitor of neutrophil adhesion dependent on the integrin LFA-1, and by reciprocal higher expression of interleukin 17 (IL-17). Consistent with that, IL-17 inhibited gingival endothelial cell expression of Del-1, thereby promoting LFA-1-dependent recruitment of neutrophils. Young Del-1-deficient mice developed spontaneous periodontitis that featured excessive neutrophil infiltration and IL-17 expression; disease was prevented in mice doubly deficient in Del-1 and LFA-1 or in Del-1 and the IL-17 receptor. Locally administered Del-1 inhibited IL-17 production, neutrophil accumulation and bone loss. Therefore, Del-1 suppressed LFA-1-dependent recruitment of neutrophils and IL-17-triggered inflammatory pathology and may thus be a promising therapeutic agent for inflammatory diseases.
Trained immunity in chronic inflammatory diseases and cancer.
Hajishengallis G, Netea M, Chavakis T Nat Rev Immunol. 2025; .
PMID: 39891000 DOI: 10.1038/s41577-025-01132-x.
The impact of aging on neutrophil functions and the contribution to periodontitis.
Wang Z, Saxena A, Yan W, Uriarte S, Siqueira R, Li X Int J Oral Sci. 2025; 17(1):10.
PMID: 39819982 PMC: 11739572. DOI: 10.1038/s41368-024-00332-w.
Using genetics to explore complement C5 as a druggable protein in periodontitis.
Alayash Z, Baumeister S, Holtfreter B, Kocher T, Baurecht H, Ehmke B Front Immunol. 2024; 15:1407431.
PMID: 39439802 PMC: 11493656. DOI: 10.3389/fimmu.2024.1407431.
Cellular senescence: A new perspective on the suppression of periodontitis (Review).
Lin X, Yuan Q, Zhou J, Dong Y, Sunchuri D, Guo Z Mol Med Rep. 2024; 30(6).
PMID: 39422030 PMC: 11529191. DOI: 10.3892/mmr.2024.13362.
Nabiyeva Cevik N, Berker E, Tezcan I, Cagdas D Clin Exp Immunol. 2024; 219(1).
PMID: 39412215 PMC: 11773607. DOI: 10.1093/cei/uxae089.